Otolaryngology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Eur J Endocrinol. 2022 Mar 23;186(5):535-542. doi: 10.1530/EJE-21-0813.
The aim of this study was to report the rationale and selection criteria for hemithyroidectomy and ipsilateral central neck dissection in patients with selected papillary thyroid cancer and to report the surgical and oncological outcomes.
Single-institution retrospective observational study.
The clinical records of patients with a histopathological diagnosis of low-risk pT1 papillary thyroid cancer who underwent hemithyroidectomy with or without ipsilateral central neck dissection between March 2000 and April 2018 at a tertiary referral center were retrospectively reviewed. Demographic, clinical, and histopathological data were collected.
During the study period, 176 patients underwent hemithyroidectomy for PTC. Thirteen patients (13/176, 7.39%) were lost to follow-up and 74 patients (74/163 45.40%) underwent completion thyroidectomy within 1 month because they were classified intermediate ATA initial risk based on definitive pathology. The final study group was composed of 89 patients, who had a median follow-up of 5.3 years. The mean follow-up was 6.3 years (range: 36-207 months). Eighty-four patients (94.38%) did not experience recurrence in the follow-up period. A total of 5/89 patients (5.62%) underwent delayed completion thyroidectomy with or without neck dissection for recurrent malignancy in the residual lobe (3/5) or regional lymph nodes (2/5). The median time from surgery to recurrence was 24.8 months (range: 6-60). The follicular variant was an independent risk factor for recurrence.
Hemithyroidectomy with or without prophylactic ipsilateral central neck dissection is a valuable treatment option in selected low-risk papillary thyroid cancers and ensures a low risk of recurrence. Prophylactic ipsilateral central compartment dissection could have a role in improving cancer staging, and accurate ultrasonographic follow-up is essential to identify local recurrence.
本研究旨在报告在选定的甲状腺乳头状癌患者中进行甲状腺半切术和同侧中央颈部清扫术的原理和选择标准,并报告手术和肿瘤学结果。
单机构回顾性观察研究。
回顾性分析 2000 年 3 月至 2018 年 4 月在一家三级转诊中心接受甲状腺半切术加或不加同侧中央颈部清扫术的低危 pT1 甲状腺乳头状癌患者的临床记录。收集人口统计学、临床和组织病理学数据。
在研究期间,176 例患者因 PTC 接受甲状腺半切术。13 例(13/176,7.39%)失访,74 例(74/163,45.40%)因根据明确病理分类为中危 ATA 初始风险而在 1 个月内行甲状腺全切术。最终研究组由 89 例患者组成,中位随访时间为 5.3 年。平均随访时间为 6.3 年(范围:36-207 个月)。84 例(94.38%)患者在随访期间未复发。5 例(5.62%)/89 例患者因残叶(3/5)或区域淋巴结(2/5)复发恶性肿瘤而接受延迟性甲状腺全切术加或不加颈部清扫术。从手术到复发的中位时间为 24.8 个月(范围:6-60)。滤泡型是复发的独立危险因素。
甲状腺半切术加或不加预防性同侧中央颈部清扫术是治疗选定的低危甲状腺乳头状癌的一种有价值的治疗选择,可确保低复发风险。预防性同侧中央区清扫术可能在改善癌症分期方面发挥作用,准确的超声随访对于识别局部复发至关重要。